| Primary |
| Depression |
40.0% |
| Anxiety |
10.8% |
| Bipolar Disorder |
6.2% |
| Hypothyroidism |
6.2% |
| Obsessive-compulsive Disorder |
6.2% |
| Abdominal Discomfort |
3.1% |
| Agitation |
3.1% |
| Antiplatelet Therapy |
3.1% |
| Insomnia |
3.1% |
| Obesity |
3.1% |
| Panic Reaction |
3.1% |
| Post Viral Fatigue Syndrome |
3.1% |
| Depressed Mood |
1.5% |
| Epilepsy |
1.5% |
| Major Depression |
1.5% |
| Muscle Spasms |
1.5% |
| Post-traumatic Stress Disorder |
1.5% |
| Schizophrenia |
1.5% |
|
| Throat Tightness |
8.8% |
| Weight Increased |
8.8% |
| Blood Creatine Phosphokinase Increased |
5.9% |
| Drug Exposure During Pregnancy |
5.9% |
| Gastric Bypass |
5.9% |
| Nausea |
5.9% |
| No Adverse Event |
5.9% |
| Obsessive-compulsive Disorder |
5.9% |
| Ovarian Cyst |
5.9% |
| Thinking Abnormal |
5.9% |
| Thrombocytopenia |
5.9% |
| Weight Decreased |
5.9% |
| Anxiety |
2.9% |
| Blood Potassium Decreased |
2.9% |
| Cardiac Operation |
2.9% |
| Cardiomyopathy |
2.9% |
| Cardiovascular Disorder |
2.9% |
| Coeliac Disease |
2.9% |
| Completed Suicide |
2.9% |
| Conduction Disorder |
2.9% |
|
| Secondary |
| Anxiety |
22.2% |
| Depression |
22.2% |
| Panic Reaction |
11.1% |
| Product Used For Unknown Indication |
7.4% |
| Abdominal Discomfort |
3.7% |
| Affective Disorder |
3.7% |
| Bipolar Disorder |
3.7% |
| Epilepsy |
3.7% |
| Hypothyroidism |
3.7% |
| Muscle Spasms |
3.7% |
| Obsessive-compulsive Disorder |
3.7% |
| Schizoaffective Disorder |
3.7% |
| Depressed Mood |
1.9% |
| Multiple Sclerosis |
1.9% |
| Schizophrenia |
1.9% |
| Smoking Cessation Therapy |
1.9% |
|
| Neonatal Asphyxia |
22.2% |
| Drug Interaction |
14.8% |
| Appendicitis |
11.1% |
| Hyperprolactinaemia |
7.4% |
| Rash |
7.4% |
| Thinking Abnormal |
7.4% |
| Gastric Bypass |
3.7% |
| Prolonged Labour |
3.7% |
| Psychiatric Symptom |
3.7% |
| Pulmonary Embolism |
3.7% |
| Scratch |
3.7% |
| Tooth Infection |
3.7% |
| Urinary Tract Infection |
3.7% |
| Weight Increased |
3.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
43.6% |
| Depression |
12.2% |
| Product Used For Unknown Indication |
8.5% |
| Anxiety |
7.4% |
| Schizophrenia |
3.7% |
| Erectile Dysfunction |
2.7% |
| Asthma |
2.1% |
| Contraception |
2.1% |
| Multiple Sclerosis |
2.1% |
| Stress |
2.1% |
| Antidepressant Therapy |
1.6% |
| Breast Cancer |
1.6% |
| Crohn's Disease |
1.6% |
| Dyspepsia |
1.6% |
| Hepatitis C |
1.6% |
| Ankylosing Spondylitis |
1.1% |
| Blood Pressure Increased |
1.1% |
| Cognitive Disorder |
1.1% |
| Hiv Infection |
1.1% |
| Hormone Replacement Therapy |
1.1% |
|
| Withdrawal Syndrome |
23.1% |
| Vomiting |
10.8% |
| Tremor |
9.2% |
| Tearfulness |
6.2% |
| Muscle Spasms |
4.6% |
| Pain In Extremity |
4.6% |
| Thinking Abnormal |
4.6% |
| Transient Ischaemic Attack |
4.6% |
| Wheezing |
4.6% |
| Neonatal Disorder |
3.1% |
| Partial Seizures |
3.1% |
| Sinus Tachycardia |
3.1% |
| Suicidal Ideation |
3.1% |
| Talipes |
3.1% |
| Uterine Leiomyoma |
3.1% |
| Weight Increased |
3.1% |
| Amaurosis Fugax |
1.5% |
| Anaphylactic Shock |
1.5% |
| Aortic Valve Stenosis |
1.5% |
| Bladder Cancer Recurrent |
1.5% |
|
| Interacting |
| Agitation |
33.3% |
| Anxiety |
33.3% |
| Depression |
33.3% |
|
| Thrombocytopenia |
66.7% |
| Overdose |
33.3% |
|
